➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Dow
Boehringer Ingelheim
Harvard Business School
AstraZeneca
McKinsey

Last Updated: June 14, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Perazine


Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug Perazine?

Perazine is an investigational drug.

There have been 21 clinical trials for Perazine. The most recent clinical trial was a Phase 2 trial, which was initiated on November 1st 2014.

The most common disease conditions in clinical trials are Headache, Migraine Disorders, and Schizophrenia. The leading clinical trial sponsors are National Cancer Institute (NCI), Alexza Pharmaceuticals, Inc., and Canadian Institutes of Health Research (CIHR).

There are three hundred and ten US patents protecting this investigational drug and three international patents.

Recent Clinical Trials for Perazine
TitleSponsorPhase
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 MutationsNational Cancer Institute (NCI)Phase 3
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 MutationsChildren's Oncology GroupPhase 3
Paracervical Injection for Headache in the Emergency DepartmentChristian Fromm, MDPhase 2

See all Perazine clinical trials

Clinical Trial Summary for Perazine

Top disease conditions for Perazine
Top clinical trial sponsors for Perazine

See all Perazine clinical trials

US Patents for Perazine

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Perazine   Get Started Free COMT inhibiting methods and compositions LIEBER INSTITUTE FOR BRAIN DEVELOPMENT (Baltimore, MD)   Get Started Free
Perazine   Get Started Free Methods of treating acanthamoeba infection using apocynin UNIVERSITY OF SOUTH FLORIDA (Tampa, FL)   Get Started Free
Perazine   Get Started Free Abuse-proofed dosage form GRUNENTHAL GMBH (Aachen, DE)   Get Started Free
Perazine   Get Started Free Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc GRUENENTHAL GMBH (Aachen, DE)   Get Started Free
Perazine   Get Started Free Treatment using truncated Trk B and Trk C antagonists OTONOMY, INC. (San Diego, CA)   Get Started Free
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Perazine

Drugname Country Document Number Estimated Expiration Related US Patent
Perazine Canada CA2975398 2035-01-30   Get Started Free
Perazine European Patent Office EP3250209 2035-01-30   Get Started Free
Perazine Japan JP2018503695 2035-01-30   Get Started Free
Perazine World Intellectual Property Organization (WIPO) WO2016123576 2035-01-30   Get Started Free
Perazine Argentina AR045352 2023-08-06   Get Started Free
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
McKesson
AstraZeneca
McKinsey
Boehringer Ingelheim
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.